Apoptosis gene polymorphisms and the risk of non-small cell lung cancer
Monica Ter-Minassian,Rihong Zhai,Kofi Asomaning,Li Su,Thomas J. Lynch,John C. Wain,Xihong Lin,David C. Christiani
IF: 11.2
2008-01-01
Cancer Research
Abstract:3118 BACKGROUND: Apoptosis (programmed cell death) plays an important role in targeting cancer cells for destruction. Defects in this process can lead to the unchecked cell growth and proliferation. Various single nucleotide polymorphisms (SNPs) in apoptotic genes have been associated with increased risks in lung cancer, particularly FAS -1377G>A (in LD with rs1800682), FASL -844 T>C , IL1B 3954 C>T Phe105Phe (rs1143634) and BAT3 Ser625Pro (rs1052486). FASL is the ligand of FAS, a member if the TNF superfamily of death receptors, which upon binding, initiate the extrinsic pathway of apoptosis. Interleukin 1 cytokine IL1B is another important initiator. BAT3, HLA-B associated transcript 3, is involved in intrinsic apoptosis by its interaction with p53. METHODS: We studied the association of these SNPs with non-small cell lung cancer (NSCLC) using a large case-control study (N=4270: 2651 cases, 1619 controls, restricted to Caucasians). We used multiple logistic regression, adjusting for age, gender, smoking status, square root of pack years, and years since smoking cessation for ex-smokers, with a co-dominant genetic model. Interactions with smoking status, pack years, age (split at 60yrs, the control median), and gender were tested by stratification and the likelihood ratio test (LRT) for interaction terms. We also conducted a case only analysis for cell type and cancer stage. RESULTS: Minor allele frequencies in controls, were 48% for BAT3 S625P, (HWE p-value=0.84), 13% for FAS -1377G>A , (HWE p=0.75), 38% for FASL -844 T>C , (HWE p =0.25) and 23% for IL1B 3954 C>T , (HWE p=0.12). Adjusted main effects ORs for all 4 SNPs were not associated with NSCLC. Tests for trend were also not significant. There was a significant modification of genotype and risk by age: for those under age 60, the FASL -844 CT vs . TT was associated with an aOR= 1.58 (1.22, 2.05), p=0.0006; and the FASL -844 CC vs. TT aOR= 1.45 (1.01, 2.04) p=0.04. In comparison, for those over age 60, the FASL -844 CT vs . TT aOR= 0.91 (0.73, 1.13), p=0.37; and the FASL -844 CC vs. TT OR= 0.86 (0.64, 1.16) p=0.32. The LRT p-value of the age-genotype interaction was p=0.004. Examination of effect modification of the genotype by smoking status, (current, former and never smokers), revealed that IL1B +3954 TT vs. CC confers a deleterious effect, significant for ex-smokers, aOR= 1.74 (1.06, 2.85), p=0.03, but for never smokers aOR= 0.77 (0.33, 1.79) p=0.55 and current smokers aOR= 0.79 (0.39, 1.59) p=0.5. The LRT of smoking-genotype interaction was not significant (p=0.24). Only FASL -844 T>C showed a significant LRT smoking-genotype interaction (p=0.03), but there was no significant association between this SNP and NSCLC risk for each smoking group. CONCLUSION: Our findings suggest age and smoking modify the association of the FASL -844 and IL1B +3954 SNPs respectively with the risk of NSCLC.